Jag to replace HIV cocktail crosses final trials hurdle

Patients infected with HIV could soon be offered a longlasting injection to control the virus and keep Aids at bay.

Results from a pivotal Phase III trial show the monthly jab is as effective as the standard current treatment that involves taking a daily cocktail of pills.

A Phase III trial is the final testing hurdle before a new drug can be licensed.

Replacing a daily regimen of multiple pills with a single injection is expected to improve compliance and ensure more patients get the treatment they need.

As a result, the jab could also help to reduce the spread of HIV, which can develop into full-blown Aids.